ATAZANAVIR Mepha caps 300 mg bte 30 pce
7680663390033
CH-66339
J05AE08
08.03.0.
1 / 3
google
Details
- Product number
- 6633903
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- atazanavirum 300 mg ut atazanaviri sulfas 341.744 mg, lactosum monohydricum 134.406 mg, crospovidonum, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Articles (1)
Atazanavir-Mepha 300mg, Kapseln
Kapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
341.744 MG | Substance | WIZUS |
|
(N/A)
|
134.406 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 401.10
Specialties list
Yes
Generic
Yes
SL addition date:
01/06/2019
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66339
- Drug name
- Atazanavir-Mepha, Kapseln
- Galenic form
- KAPS
- ATC Code
- J05AE08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/09/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ATAZANAVIR Mepha caps 300 mg bte 30 pce
- Description (DE)
- ATAZANAVIR Mepha Kaps 300 mg Ds 30 Stk
- Market launch
- 19/09/2017
- Narcotic (BTM)
- No